No AVH can only do little patches, no good for large areas I believe. Could be good in combination with CUV Scenesse to 'touch up' any problematic areas and due to the non-immune suppressing nature of the Clinuvel product it should become the standard of care. It is really fantastic how the competition in EPP has dropped right away, I will analyse this more when I get a chance, but I believe that Vitiligo will be FDA approved before any competition arises in EPP which is really great for shareholders.
All IMO DYOR
No AVH can only do little patches, no good for large areas I...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.16 |
Change
0.090(0.60%) |
Mkt cap ! $759.1M | |||
| Open | High | Low | Value | Volume |
| $15.12 | $15.44 | $15.02 | $1.063M | 70.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 126 | $15.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 764 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |